ESAB
ESAB NYSE Industrial Machinery & Supplies & Components Financials FY2020βFY2025
ESAB's revenue rose 3.7% to $2.8 billion in fiscal 2025. Its operating margin was 14.5%, down from 16.3% a year earlier. Free cash flow was $213 million, down 29.8%. It paid out $22 million in dividends and buybacks, 10% of free cash flow. The diluted share count rose 0.3%.
What ESAB does
No business description yet.
- Legal name
- ESAB Corporation
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001877322-26-000007
0001877322
Revenue and margins
ESAB had $2.8B of revenue in fiscal 2025, up 3.7% on the year before.
Net income and earnings per share
From fiscal 2020 to 2025, diluted EPS grew 7.0% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $213M in fiscal 2025, 7.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
ESAB returned $21.9M to shareholders in fiscal 2025, 10% of free cash flow. The diluted share count rose 0.3%.
Value ESAB yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$1.0B and divides by 61.3M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 24.1x Β· peers 32.3x Β· sector 26.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably ESAB can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $41.2M | $72.0M | $102M | $249M | $186M |
| Debt incl. finance leases | $0.0M | $1.2B | $1.0B | $1.1B | $1.2B |
| Net debt / EBITDA | β0.1x | 2.9x | 1.9x | 1.6x | 2.1x |
| Debt / equity | 0.0x | 0.9x | 0.6x | 0.6x | 0.6x |
| Interest coverage | β | 9.5x | 5.1x | 7.2x | 6.2x |
| Current ratio | 1.6x | 1.6x | 1.6x | 1.8x | 1.9x |
| Quick ratio | 0.9x | 1.0x | 1.0x | 1.2x | 1.2x |
| Total assets | $3.5B | $3.8B | $3.8B | $4.0B | $4.8B |
| Total liabilities | $960M | $2.4B | $2.2B | $2.2B | $2.6B |
| Shareholders' equity | $2.5B | $1.4B | $1.6B | $1.8B | $2.2B |
| Net debt (β = net cash) | β$41.2M | $1.1B | $916M | $826M | $1.0B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$8.9M
5 insiders
Of sales under plans
95%
$8.4M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | Rhonda L JordanDirector | Sold | 1,000 | $95.00 | $0.1M | Form 4 |
| Feb 27, 2026 | Michele CampionChief Human Resources Officer | Sold plan | 5,096 | $122.63 | $0.6M | Form 4 |
| Feb 23, 2026 | Shyam KambeyandaPresident and CEO, Director | Sold plan | 59,404 | $123.79 | $7.4M | Form 4 |
| Feb 6, 2026 | Kevin J JohnsonChief Financial Officer | Sold plan | 3,494 | $134.62 | $0.5M | Form 4 |
| Nov 11, 2025 | Rajiv VinnakotaDirector | Sold | 2,783 | $114.50 | $0.3M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 5 / 9 | 6 / 9 | 4 / 9 |
| Accruals ratio | β3.3% | β2.3% | β0.8% |
| Altman Z'' | 2.45 | 2.92 | 2.86 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| ESAB ESAB | $4.1B | 3.7% | 14.5% | 7.5% | 11.0% | 24.1x | 4 | |
| Nordson NDSN | $17.9B | 3.8% | 25.5% | 23.7% | 11.6% | 32.3x | 5 | Compare β |
| Carpenter Technology CRS | $14.2B | 8.6% | 22.5% | 11.6% | 23.7% | 25.1x | 9 | Compare β |
| Middleby MIDD | $5.1B | 1.6% | 18.0% | 17.5% | 8.7% | β | 4 | Compare β |
| IDEX IEX | $17.0B | 5.8% | 20.2% | 17.8% | 10.2% | 33.0x | 7 | Compare β |
6 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $2.0B | $2.4B | $2.6B | $2.8B | $2.7B | $2.8B |
| Gross profit | $683M | $838M | $886M | $1.0B | $1.0B | $1.0B |
| Research and development | $34.8M | $39.7M | $36.0M | $38.8M | $39.2M | $44.0M |
| Operating income | $202M | $306M | $329M | $404M | $447M | $412M |
| Interest expense | $0.0M | $0.0M | $34.7M | $79.1M | $62.3M | $66.6M |
| Pretax income | $206M | $319M | $300M | $319M | $370M | $328M |
| Income tax | $46.0M | $80.4M | $69.2M | $95.7M | $77.3M | $69.2M |
| Net income | $157M | $235M | $224M | $205M | $265M | $227M |
| Diluted EPS | $2.62 | $3.92 | $3.69 | $3.36 | $4.31 | $3.67 |
| Diluted shares | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B |
| Cash flow | ||||||
| Cash from operations | $309M | $251M | $214M | $331M | $355M | $261M |
| Capital expenditure | $40.1M | $35.6M | $40.2M | $48.2M | $51.8M | $47.3M |
| Free cash flow | $269M | $215M | $174M | $282M | $304M | $213M |
| Depreciation and amortization | $76.6M | $75.9M | $66.0M | $75.0M | $66.8M | $84.1M |
| Stock-based compensation | $6.4M | $6.3M | $13.0M | $16.1M | $19.8M | $16.9M |
| Acquisitions | $0.0M | $4.9M | $149M | $18.7M | $154M | $438M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends paid | $0.0M | $0.0M | $6.1M | $13.3M | $17.0M | $21.9M |
| Dividends and buybacks | $0.0M | $0.0M | $6.1M | $13.3M | $17.0M | $21.9M |
| Balance sheet | ||||||
| Cash and short-term investments | $49.2M | $41.2M | $72.0M | $102M | $249M | $186M |
| Total debt | β | $0.0M | $1.2B | $1.0B | $1.1B | $1.2B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | β | $964M | $989M | $998M | $1.1B | $1.3B |
| Current liabilities | β | $597M | $602M | $620M | $632M | $665M |
| Inventory | $0.0M | $420M | $417M | $393M | $404M | $482M |
| Property and equipment, net | β | $286M | $284M | $294M | $298M | $382M |
| Total assets | β | $3.5B | $3.8B | $3.8B | $4.0B | $4.8B |
| Total liabilities | β | $960M | $2.4B | $2.2B | $2.2B | $2.6B |
| Shareholders' equity | $2.5B | $2.5B | $1.4B | $1.6B | $1.8B | $2.2B |
| Margins | ||||||
| Gross margin | 35.0% | 34.5% | 34.1% | 36.6% | 37.9% | 36.9% |
| Operating margin | 10.4% | 12.6% | 12.7% | 14.6% | 16.3% | 14.5% |
| EBITDA margin | 14.3% | 15.7% | 15.2% | 17.3% | 18.8% | 17.5% |
| Net margin | 8.1% | 9.7% | 8.6% | 7.4% | 9.7% | 8.0% |
| FCF margin | 13.8% | 8.9% | 6.7% | 10.2% | 11.1% | 7.5% |
| Returns | ||||||
| Return on capital | β | β | 10.1% | 11.1% | 13.6% | 11.0% |
| Return on capital employed | β | β | 10.9% | 12.7% | 13.5% | 11.0% |
| Return on equity | β | β | 11.7% | 13.9% | 15.7% | 11.5% |
| Return on assets | β | β | 6.2% | 5.4% | 6.7% | 5.2% |
| Growth | ||||||
| Revenue growth | β | 24.5% | 6.8% | 7.0% | β1.2% | 3.7% |
| Net income growth | β | 49.4% | β4.8% | β8.3% | 29.0% | β14.4% |
| EPS growth | β | 49.6% | β5.9% | β8.9% | 28.3% | β14.9% |
| FCF growth | β | β20.0% | β19.1% | 62.1% | 7.6% | β29.8% |
| Share count change | β | 0.0% | 0.2% | 0.8% | 0.7% | 0.3% |
| Financial health | ||||||
| Net debt / EBITDA | β | β0.1x | 2.9x | 1.9x | 1.6x | 2.1x |
| Debt / equity | β | 0.0x | 0.9x | 0.6x | 0.6x | 0.6x |
| Interest coverage | β | β | 9.5x | 5.1x | 7.2x | 6.2x |
| Current ratio | β | 1.6x | 1.6x | 1.6x | 1.8x | 1.9x |
| Quick ratio | β | 0.9x | 1.0x | 1.0x | 1.2x | 1.2x |
| Capital allocation | ||||||
| Capex / revenue | 2.1% | 1.5% | 1.6% | 1.7% | 1.9% | 1.7% |
| Stock comp / revenue | 0.3% | 0.3% | 0.5% | 0.6% | 0.7% | 0.6% |
| Payouts / FCF | 0.0% | 0.0% | 3.5% | 4.7% | 5.6% | 10.3% |
| Quality scores | ||||||
| Piotroski F-score | β | β | β | 5.0 | 6.0 | 4.0 |
| Altman Z'' | β | 4.0 | 2.0 | 2.5 | 2.9 | 2.9 |
| Accruals ratio | β | β | 0.3% | β3.3% | β2.3% | β0.8% |
Source: SEC EDGAR XBRL filings (CIK 0001877322). Data updated October 16, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.